Clinical Activity and Safety of Anti-Programmed Death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in Patients (PTS) with Previously Treated, Metastatic Renal Cell Carcinoma (MRCC)
暂无分享,去创建一个
David C. Smith | T. Choueiri | M. Atkins | C. Drake | M. Sznol | J. Wigginton | A. Gupta | G. Kollia | D. McDermott | J. Powderly